Microplastics are increasingly recognized as environmental contaminants with potential implications for human health. The gastrointestinal tract serves as a primary route of exposure, leading to interactions between ingested particles and the gut ecosystem. Research indicates that microplastics can modify the composition of the gut microbiota, potentially reducing diversity and altering the abundance of specific bacterial taxa.
Microplastic-Induced Physiological Changes
Studies suggest that microplastic interactions can activate inflammatory pathways, including TLR4/NF-κB signaling, by facilitating the translocation of bacterial products. Simultaneously, alterations in microbial metabolism, such as changes in short-chain fatty acids, bile acid metabolism, and tryptophan-derived metabolites, are observed. These changes are linked to potential disruptions in insulin resistance, hepatic lipid dysregulation, and the gut-brain axis.
Challenges in Human Research
Currently, the majority of evidence originates from animal and in vitro models. Establishing causal relationships in humans remains challenging due to limitations including inconsistent exposure protocols, variations in particle characterization, and a lack of comprehensive human data. These factors contribute to difficulties in isolating the specific effects of microplastics from associated chemical contaminants.
Future research should incorporate realistic exposure models, standardized microbiome analyses, and multi-omics approaches alongside human cohort designs. Continued investigation is necessary to fully understand the complex interactions between microplastics and the gut microbiota, and to determine their role in human health and disease susceptibility.”}